摘要
目的了解Notch1基因在淋巴细胞肿瘤中的表达特点。方法采用SYBRGreenⅠ荧光定量PCR和相对定量分析法检测43例淋巴细胞肿瘤患者(T细胞急性淋巴细胞白血病7例、T细胞非霍奇金淋巴瘤6例、B细胞急性淋巴细胞白血病9例、B细胞慢性淋巴细胞白血病5例和B细胞非霍奇金淋巴瘤16例)和20例健康人外周血单个核细胞的Notch1基因表达水平,以β2微球蛋白基因(β2M)作为内参,采用公式2-ΔCt×100%计算Notch1基因表达水平。结果 T细胞肿瘤组(中位数0.897%)与B细胞肿瘤组(中位数0.726%)患者外周血单个核细胞Notch1基因表达均比健康对照组(中位数0.288%)明显上升(P<0.01,P<0.01)。T细胞肿瘤组Notch1基因表达水平与B细胞肿瘤组的差异无统计学意义(P>0.05)。但五种类型淋巴细胞肿瘤Notch1基因表达水平有所不同,其中以B细胞慢性淋巴细胞白血病组最高,其次是T细胞非霍奇金淋巴瘤组,而B细胞非霍奇金淋巴瘤组的Notch1基因表达水平最低。结论异常高表达的Notch1基因可能与参与淋巴细胞肿瘤的发生发展过程,研究结果为靶向抑制Notch1的基因治疗提供初步依据。
Objective To investigate the expression level of Notch1 gene in patients with lymphoid malignancies.Methods Real-time PCR with SYBR GreenⅠ technique was used to detect Notch1 gene expression level in peripheral blood mononuclear cells of 43 patients with lymphoid malignancies,including 7 cases with T-ALL,6 cases with T-NHL,9 cases with B-ALL,5 cases with B-CLL,16 cases with B-NHL] and 20 healthy individuals.β2-microglobulin gene(β2M) was used as an endogenous control.Relative level of Notch1 gene expression were analysed by the 2-ΔCt×100% method.Results The expression level of Notch1 in both T-cell lymphoid malignancies group(Median:0.897%) and B-cell lymphoid malignancies group(Median:0.726%) was significant higher than that in the healthy control(Median:0.288%)(P0.01,P0.01).However,the expression level of Notch1 was different in the five types of lymphoid malignancies.The highest level was observed in the B-CLL group,secondary in the T-NHL group,the lowest in the B-NHL group.Conclusions The abnormal expression of Notch1 might played an important role in the pathogenesis of lymphoid malignancies.The result provided the preliminary basis for targeting the Notch1 pathways.
出处
《肿瘤防治研究》
CAS
CSCD
北大核心
2010年第10期1140-1143,共4页
Cancer Research on Prevention and Treatment
基金
国家自然科学基金资助项目(30871091)